FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3132213426> ?p ?o ?g. }

• W3132213426 endingPage "539" @default.
• W3132213426 startingPage "529" @default.
• W3132213426 abstract "Because of the chronic nature of giant cell arteritis (GCA) and/or polymyalgia rheumatica (PMR), patients may require continued glucocorticoid treatment to achieve treatment targets or prevent disease relapse, resulting in high cumulative doses. This study evaluated patterns of glucocorticoid use and outcomes in patients with GCA, PMR, or both. This retrospective study used electronic medical records from a US rheumatology clinic utilizing the JointMan® (Discus Analytics, LLC) rheumatology software. Patients aged ≥ 50 years with a diagnosis of GCA or PMR and ≥ 1 entry for a glucocorticoid prescription after diagnosis were included. Outcomes at 2 years after glucocorticoid initiation included the proportion of patients discontinuing glucocorticoids for ≥ 6 months, proportion of patients discontinuing glucocorticoids for ≥ 6 months and remaining off glucocorticoids at 2 years, time to discontinuation of glucocorticoids for ≥ 6 months, and prednisone dose and were compared between patients with GCA only, PMR only, or GCA and PMR. At 2 years after the initiation of glucocorticoids, 32% of patients (26/91) with GCA, 32% (248/779) with PMR, and 27% (26/97) with GCA and PMR discontinued glucocorticoids for ≥ 6 months; 17, 23, and 18% discontinued glucocorticoids for ≥ 6 months and remained off glucocorticoids at 2 years, respectively. Median (range) time to discontinuation of glucocorticoids for ≥ 6 months was 202.5 (0–635) days and shorter in patients with both GCA and PMR vs. GCA or PMR only. The majority of patients required daily prednisone at 2 years, with similar doses observed between groups. Fewer than one-third of patients with GCA and/or PMR discontinued glucocorticoids for ≥ 6 months; the majority of patients required prednisone therapy for ≥ 2 years after its initiation. These data highlight the need for the use of more efficacious and glucocorticoid-sparing therapies in patients with GCA and/or PMR." @default.
• W3132213426 created "2021-03-01" @default.
• W3132213426 creator A5000643400 @default.
• W3132213426 creator A5017443500 @default.
• W3132213426 creator A5040865719 @default.
• W3132213426 creator A5058267822 @default.
• W3132213426 creator A5091071705 @default.
• W3132213426 date "2021-02-26" @default.
• W3132213426 modified "2023-10-17" @default.
• W3132213426 title "Treatment Patterns, Disease Burden, and Outcomes in Patients with Giant Cell Arteritis and Polymyalgia Rheumatica: A Real-World, Electronic Health Record-Based Study of Patients in Clinical Practice" @default.
• W3132213426 cites W1488642175 @default.
• W3132213426 cites W1995278898 @default.
• W3132213426 cites W2015898677 @default.
• W3132213426 cites W2025001196 @default.
• W3132213426 cites W2055016657 @default.
• W3132213426 cites W2125206659 @default.
• W3132213426 cites W2127445888 @default.
• W3132213426 cites W2146119217 @default.
• W3132213426 cites W2149841789 @default.
• W3132213426 cites W2163122962 @default.
• W3132213426 cites W2276407132 @default.
• W3132213426 cites W2290444582 @default.
• W3132213426 cites W2292169217 @default.
• W3132213426 cites W2292748966 @default.
• W3132213426 cites W2415454392 @default.
• W3132213426 cites W2427523709 @default.
• W3132213426 cites W2527887155 @default.
• W3132213426 cites W2558363236 @default.
• W3132213426 cites W2736027399 @default.
• W3132213426 cites W2737436316 @default.
• W3132213426 cites W2767898276 @default.
• W3132213426 cites W2775021382 @default.
• W3132213426 cites W2793684398 @default.
• W3132213426 cites W2799432007 @default.
• W3132213426 cites W2898053476 @default.
• W3132213426 cites W2954943567 @default.
• W3132213426 cites W2966434349 @default.
• W3132213426 cites W2972634229 @default.
• W3132213426 cites W2980985033 @default.
• W3132213426 cites W4211106135 @default.
• W3132213426 cites W4294350876 @default.
• W3132213426 doi "https://doi.org/10.1007/s40744-021-00290-3" @default.
• W3132213426 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7991019" @default.
• W3132213426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33638132" @default.
• W3132213426 hasPublicationYear "2021" @default.
• W3132213426 type Work @default.
• W3132213426 sameAs 3132213426 @default.
• W3132213426 citedByCount "1" @default.
• W3132213426 countsByYear W31322134262022 @default.
• W3132213426 crossrefType "journal-article" @default.
• W3132213426 hasAuthorship W3132213426A5000643400 @default.
• W3132213426 hasAuthorship W3132213426A5017443500 @default.
• W3132213426 hasAuthorship W3132213426A5040865719 @default.
• W3132213426 hasAuthorship W3132213426A5058267822 @default.
• W3132213426 hasAuthorship W3132213426A5091071705 @default.
• W3132213426 hasBestOaLocation W31322134261 @default.
• W3132213426 hasConcept C126322002 @default.
• W3132213426 hasConcept C167135981 @default.
• W3132213426 hasConcept C195910791 @default.
• W3132213426 hasConcept C198451711 @default.
• W3132213426 hasConcept C2776015282 @default.
• W3132213426 hasConcept C2776712624 @default.
• W3132213426 hasConcept C2776715498 @default.
• W3132213426 hasConcept C2778715236 @default.
• W3132213426 hasConcept C2778720950 @default.
• W3132213426 hasConcept C2779134260 @default.
• W3132213426 hasConcept C2780079024 @default.
• W3132213426 hasConcept C2780841215 @default.
• W3132213426 hasConcept C2781343717 @default.
• W3132213426 hasConcept C71924100 @default.
• W3132213426 hasConceptScore W3132213426C126322002 @default.
• W3132213426 hasConceptScore W3132213426C167135981 @default.
• W3132213426 hasConceptScore W3132213426C195910791 @default.
• W3132213426 hasConceptScore W3132213426C198451711 @default.
• W3132213426 hasConceptScore W3132213426C2776015282 @default.
• W3132213426 hasConceptScore W3132213426C2776712624 @default.
• W3132213426 hasConceptScore W3132213426C2776715498 @default.
• W3132213426 hasConceptScore W3132213426C2778715236 @default.
• W3132213426 hasConceptScore W3132213426C2778720950 @default.
• W3132213426 hasConceptScore W3132213426C2779134260 @default.
• W3132213426 hasConceptScore W3132213426C2780079024 @default.
• W3132213426 hasConceptScore W3132213426C2780841215 @default.
• W3132213426 hasConceptScore W3132213426C2781343717 @default.
• W3132213426 hasConceptScore W3132213426C71924100 @default.
• W3132213426 hasFunder F4320332193 @default.
• W3132213426 hasIssue "1" @default.
• W3132213426 hasLocation W31322134261 @default.
• W3132213426 hasLocation W31322134262 @default.
• W3132213426 hasOpenAccess W3132213426 @default.
• W3132213426 hasPrimaryLocation W31322134261 @default.
• W3132213426 hasRelatedWork W1992667969 @default.
• W3132213426 hasRelatedWork W203372729 @default.
• W3132213426 hasRelatedWork W2089514348 @default.
• W3132213426 hasRelatedWork W2100028348 @default.
• W3132213426 hasRelatedWork W2396723050 @default.
• W3132213426 hasRelatedWork W2537085646 @default.
• W3132213426 hasRelatedWork W2761395265 @default.
• W3132213426 hasRelatedWork W2950079154 @default.

• next